NEW STUDY SHOWS IMPROVED PROTOCOL REDUCED SEPSIS MORTALITY RATE BY 85 PERCENT
VALLEJO, Calif., Feb. 25, 2018 – NEWTON, Mass., Feb. 25, 2018 – Sutter Solano Medical Center, in collaboration with Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management technology, today announced the presentation of new study results at the Society of Critical Care Medicine’s 47th Annual Critical Care Congress in San Antonio, Texas. These findings demonstrate that the use of improved sepsis detection monitoring and treatment processes reduced the sepsis mortality rate by 85 percent through collaborative efforts of the Electronic Intensive Care Unit (eICU) and Sutter Solano’s ICU and Quality departments.
The results were part of a year-long study, conducted by eICU nurse Laura Maples MSN, RN, CCRN-e, to reduce the department’s rate of sepsis mortality. In addition to added staff training and education, non-invasive monitoring technology from Cheetah Medical was used to actively determine IV fluid responsiveness and improve therapy guidance in septic patients. This combination of targeted and effective patient screening, monitoring and care lead to these top-level outcome improvements:
- The original mortality rate of 41.2 percent was reduced to 6.1 percent after 12 months of study—an 85.2 percent reduction
- Ten patients had far better outcomes than anticipated
Sepsis, costing over $20 billion dollars annually, is the most expensive diagnosis to treat and the second leading cause of death in non-coronary ICUs with a mortality rate of 45 percent.[i] A 2016 report from Healthcare Cost and Utilization Project (HCUP) and the Agency for Healthcare Research and Quality shows sepsis is responsible for nearly $24 billion in annual costs.[ii] Additionally, central venous pressure (CVP) has frequently been used as a measure for hemodynamic stability; however, Maples’ research reveals that there are now more accurate methods of measurement.
“The results from this study are a clear indicator that monitoring central venous pressure, while currently an industry standard, is a poor measure for hemodynamic stability,” said Maples. “As a nurse, I’ve seen emerging technologies improve medical outcomes throughout my career. Today, I am inspired to see innovations like the biodynamic measurement of non-invasive cardiac output monitoring (NICOM) technology doing just that for septic patients. The study’s results, which required multidisciplinary and interdepartmental collaboration, have since inspired other ICUs throughout the system to also on-board this technology.”
These study results raise awareness about the benefits of additional training and education, as well as the opportunities to incorporate the use of non-invasive fluid monitoring technologies.
The oral presentation (abstract #1404), An eICU/ICU Collaborative to Reduce Sepsis Mortality, will be presented on Sunday, February 25, 2018 at 2:45 p.m. ET in Theatre 14.
About Sutter Health
Sutter Health’s integrated network of physician, employee and volunteer pioneers—more than 60,000 people strong—make it one of the nation’s top five large health systems. Rooted in Sutter Health’s not-for-profit mission, these team members partner to deliver exceptional care that feels personal. From physician offices to hospitals to outpatient care centers and home services, they proudly support and learn from the more than 3 million people in their care. Sutter care pioneers adopt new technologies, make novel discoveries, and embrace creative thinking to help patients and communities achieve their best health. From its street nurse program that provides check-ups for homeless people, to telemedicine-aided specialist consultations, to walk-in care clinics, to smart glass technology, the Sutter Health team goes beyond traditional models to make care more convenient and to nurture and empower people throughout their medical journey. For more information about the Sutter Health network, visit sutterhealth.org, facebook.com/sutterhealth, youtube.com/sutterhealth and twitter.com/sutterhealth.
About Cheetah Medical
Cheetah Medical is the pioneer and leading global provider of 100 percent non-invasive fluid management monitoring technologies, designed for use in critical care, operating room and emergency department settings. The CHEETAH Starling™ SV is fast becoming the gold standard in fluid management, as it provides immediate, dynamic assessments of fluid responsiveness, enabling clinicians to make more confident and informed treatment decisions regarding the proper amount of fluid required to maintain adequate organ and tissue perfusion. Moreover, recent research from the University of Kansas Medical Center has shown effective fluid management can reduce hospital ICU stays by an average of 2.89 days and reduce the risk of mechanical ventilation and initiation of acute dialysis, ultimately saving over $14,000 in medical costs per patient. The company’s fluid management systems currently make an impact in more than 400 hospitals throughout the U.S. and in 25+ countries. Visit www.cheetah-medical.com for more information.